The regenerative capacity of the liver is essential for recovery from surgical resection or injuries induced by trauma or toxins. During liver regeneration, the concentration of nicotinamide adenine dinucleotide (NAD) falls, at least in part due to metabolic competition for precursors. To test whether NAD availability restricts the rate of liver regeneration, we supplied nicotinamide riboside (NR), an NAD precursor, in the drinking water of mice subjected to partial hepatectomy. NR increased DNA synthesis, mitotic index, and mass restoration in the regenerating livers. Intriguingly, NR also ameliorated the steatosis that normally accompanies liver regeneration. To distinguish the role of hepatocyte NAD levels from any systemic effects of NR, we generated mice overexpressing nicotinamide phosphoribosyltransferase, a rate-limiting enzyme for NAD synthesis, specifically in the liver. Nicotinamide phosphoribosyltransferase overexpressing mice were mildly hyperglycemic at baseline and, similar to mice treated with NR, exhibited enhanced liver regeneration and reduced steatosis following partial hepatectomy. Conversely, mice lacking nicotinamide phosphoribosyltransferase in hepatocytes exhibited impaired regenerative capacity that was completely rescued by administering NR. Conclusion: NAD availability is limiting during liver regeneration, and supplementation with precursors such as NR may be therapeutic in settings of acute liver injury. (HEPATOLOGY 2017;65:616-630).
T he liver is one of the few structures that is capable of substantial regeneration in mammals and can fully regrow from less than 30% of its original mass. (1, 2) This regenerative capacity is critical to survival under conditions such as traumatic injury, exposure to hepatotoxins or infectious agents, or surgical resection of a tumor. Recovery of liver function is highly dependent upon increasing energy production necessary for restoring liver mass. (3) However, the mechanisms that are important for the liver to respond to acute and chronic injury and the biological pathways that govern the ability of the liver to regenerate are not well understood. As such, there is substantial interest in therapeutic approaches that could accelerate the regenerative process and speed the return to normal liver function in patients with severe liver injury.
It has been known for decades that a transient decrease in nicotinamide adenine dinucleotide (NAD) content accompanies the early stages of liver regeneration. (4) This has generally been attributed to competition with nucleic acid synthesis, which requires many of the same precursors and cofactors, including adenosine triphosphate (ATP) and phosphoribosylpyrophosphate. (5, 6) Both of the major routes for ATP generation, glycolysis and mitochondrial respiration, require NAD as a cofactor; and several classes of enzymes require the molecule as a cosubstrate to execute their signaling functions. (7) Thus, NAD deficiency in the injured liver might be expected to compromise both energetics and intracellular signaling, either of which could plausibly slow regeneration. Moreover, NAD deficiency in an otherwise healthy liver decreases oxidation of fatty acids and promotes steatosis, which is a characteristic feature of liver regeneration. (8) (9) (10) (11) At present, however, it remains unclear whether the changes in NAD concentration observed in vivo have a meaningful impact on liver regeneration or whether other intrinsic aspects of the regenerative process ultimately control the pace at which new hepatocytes are produced.
To directly test whether NAD availability is limiting for liver regeneration, we performed partial hepatectomy (PHx), a well-established model for liver injury, in mice given the NAD precursor nicotinamide riboside (NR) in the drinking water. To probe the role of NAD metabolism more specifically in hepatocytes, we also employed genetic strategies to overexpress or delete nicotinamide phosphoribosyltransferase (Nampt), a rate-limiting enzyme for NAD biosynthesis. Our results demonstrate that NAD availability is indeed limiting for liver regeneration and suggest that strategies to increase hepatic NAD content may be protective against liver injuries or toxic insults.
Materials and Methods

ANIMALS, HOUSING, AND DRUG TREATMENT
Mice overexpressing Nampt in hepatocytes were obtained by crossing animals carrying an exogenous copy of the Nampt complementary DNA separated from the CAGGS promoter by a floxed stop cassette that were backcrossed to the C57BL/6J background (as described (8) ) with mice carrying albumincyclization recombination (Cre; JAX strain B6.CgTg[Alb-cre]21Mgn/J, stock number 003574). Littermates lacking albumin-Cre were used as controls. For studies on the adult onset of Nampt overexpression, male Nampt fl/fl (floxed) and Nampt wt/wt (wild type) mice, 8-9 weeks old, were injected in the retroorbital plexus with adeno-associated virus expressing either Cre recombinase (AAV-Cre) or enhanced green fluorescent protein (AAV-Gfp) under the control of thyroxine-binding globulin promoter (AAV-Cre). Nampt fl/fl mice injected with AAV-Gfp and Nampt wt/wt injected with AAV-Cre served as controls. For inducible deletion of Nampt, we employed mice originally created by O. Leo at Universit e de Liège and backcrossed to the C57/BL6 background (generously provided by S.-I. Imai at Washington University). (9, 12) As above, male mice, 8-9 weeks old, bearing two floxed alleles were injected retroorbitally with AAVCre or AAV-Gfp under the control of thyroxinebinding globulin promoter. Fasting blood glucose was measured and PHx procedures were performed at >14 days after AAV infection in both the adult-onset overexpression and liver-specific knockout cohorts. Animals were housed in groups of four or five mice/cage in a pathogen-free barrier facility in a 12-hour light-dark cycle with free access to food and water. For experiments containing only WT animals, male C57BL/6J mice were ordered directly from Jackson Labs. For NR supplementation experiments, NR (Chromadex Inc.) was dissolved in the drinking water at 3.0 mg/mL in light-protected bottles and changed every 3 days. For fasting and refeeding experiments, animals were fasted for 16 hours with access to water ad libitum in cages containing Alpha-dri bedding. All animal work was performed in accordance with the US Department of Health and Human Services Guide for the Care and
PARTIAL HEPATECTOMY
Male transgenic mice, 10-14 weeks old, underwent PHx according to the protocol of Mitchell and Willenbring (10, 11) between 8:00 a.m. and noon. Briefly, after isoflurane anesthesia, a ventral midline incision was made. Then the median and left lateral lobes, comprising 70% of the liver, were resected by pedicle ligation. For 5-ethynyl-2 0 -deoxyuridine (EdU) labeling (Molecular Probes), mice were injected intraperitoneally with the labeling reagent at a dose of 16 mg/kg 12 hours before sacrifice, except for the 36-hour time point, in which case EdU was injected 5 hours before sacrifice to capture the peak of DNA synthesis. Animals were sacrificed at 24, 36, 48, and 192 hours after PHx, as indicated. The resected and regenerating livers were snap-frozen in liquid nitrogen, fixed in 4% paraformaldehyde, embedded in optimal cutting temperature medium (Tissue-TEK O.C.T. compound; Sakura), or rapidly frozen in prechilled metal clamps in liquid nitrogen for NAD and ATP assays. All surgical procedures involving mice were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania.
HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND IMMUNOFLUORESCENCE
Mitotic figures were counted in hematoxylin and eosin-stained slides. Paraffin-embedded liver sections of 5 mm thickness were deparaffinized in xylene, followed by rehydration through a graded ethanol series and staining with Gill 3 hematoxylin (Thermo Scientific) and eosin (Sigma). Mitotically active areas were first screened under lower magnification. For quantification, total mitotic counts in 10 high-power fields (340) in the most mitotically active areas were considered. Representative photomicrographs were taken at 3400 magnification using a light microscope coupled with a digital image acquisition system. For immunofluorescent detection of Nampt expression in paraffin sections, antigens were retrieved in R buffer (Electron Microscopy Sciences; catalog no. 62706-10), followed by quenching and blocking in Cas-Block (Invitrogen; 00-8120) for 20 minutes. Slides were then incubated overnight at 48C in a humidified chamber with primary rabbit polyclonal anti-NAMPT antibody (Bethyl Laboratories; dilution 1:1,000). Goat antirabbit immunoglobulin G (Alexa Fluor 488) was used as secondary antibody at a dilution of 1:600, and slides were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI; Vector Laboratories). For quantification, cells were examined and imaged using a Zeiss Axioplan 2 imaging system under a 320 objective taking both the central and portal venous areas. For Ki67 staining, paraffin-embedded liver sections were stained by the standard immunoperoxidase method, using antigen retrieval in Pickcell for 10-15 minutes in 1 3 R buffer A. Sections were incubated with rabbit monoclonal primary anti-Ki67 (Vector Laboratories; VP-RM04, 1:200) at 48C overnight. Biotinylated antirabbit secondary antibody (1:600; Vector Laboratories) was used, followed by detection with the Vectastain ABC kit. Slides were counterstained in hematoxylin. Images were captured at 3200 magnification using a Nikon E600 bright field microscope.
EdU STAINING
Paraffin-embedded liver sections were stained for EdU using either the Click-iT EdU Alexa Fluor 488 or the Alexa Fluor 594 Imaging Kit (Molecular Probes) according to the manufacturer's protocol, and five or six random areas of each liver were imaged. The fraction of EdU-positive hepatocytes was determined by counting manually at 3200 in both central vein and portal triad regions and normalizing the DAPI counterstain.
OIL RED O STAINING
Liver samples frozen in optimal cutting temperature medium were sectioned at 5 mm thickness and fixed in 10% neutral buffered formalin. Slides were placed in propylene glycol (Sigma) for 2 minutes and then incubated in oil red O (Sigma) for 10 minutes at 608C. Slides were then transferred to 85% propylene glycol solution for 1 minute and counterstained with hematoxylin (Fisher Scientific). Representative images were captured at 3200 magnification using a Nikon E600 bright field microscope coupled with a digital image acquisition system.
IMMUNOBLOTTING
For western blot analysis, snap-frozen liver pieces were lysed in radio immunoprecipitation assay buffer supplemented with Halt phosphatase inhibitors (Thermo Scientific) and complete protease inhibitors (Roche) in a tissue lyzer (Qiagen). Tissue lysates were preclarified by centrifugation at 15,000g for 15 minutes at 48C. After denaturation, samples were resolved on 4%-15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, transferred to polyvinylidene fluoride membranes (Millipore) on a wet transfer apparatus (BioRad), and probed using anti-NAMPT (Bethyl Laboratories; PBEF [A300-372A], dilution 1:5,000) and horseradish peroxidase-conjugated ß-actin (Abcam; ab49900) antibodies. Immunoreactive proteins were detected by chemiluminescence. Images were captured in a Bio-Rad imaging station using Super Signal West Femto substrates (Pierce).
GENE EXPRESSION ANALYSIS
Total RNA was extracted from frozen liver with Trizol (Sigma-Aldrich). RNA (1 mg) was reversetranscribed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer's recommendations. Real-time polymerase chain reaction was performed on an Applied Biosystems 7900HT system with SYBR green master mix (Applied Biosystems). Three technical replicates were obtained for each sample, and a relative standard curve method was used to quantify the results obtained using gene-specific primers. TATA box binding protein gene and ß-actin were used as housekeeping genes. Primers used for quantitative real-time polymerase chain reaction are listed in Supporting Table S1 .
NAD METABOLITE EXTRACTION FROM LIVER
NAD was extracted from 50 mg of clamp frozen liver in 0.6 M perchloric acid at 48C using a tissue lyzer (Qiagen) with a metal bead set at 20 Hz for 2 minutes. Insoluble materials were pelleted at 15,000g for 10 minutes at 48C, and the clear supernatant was diluted to 1:100 in ice-cold 100 mM phosphate buffer, pH 8. NAD was measured by an enzymatic cycling assay in a 96-well format modified from the procedure of Graeff and Lee (13) as described. (8) Briefly, the cycling mix was prepared freshly before use, and 5 mL of NAD standards or diluted tissue extracts were mixed with 95 mL of cycling mixture (2% ethanol, 100 mg/mL alcohol dehydrogenase, 10 mg/mL diaphorase, 20 mM resazurin, 10 mM flavin mononucleotide, 10 mM nicotinamide, and 0.1% bovine serum albumin in 100 mM phosphate buffer, pH 8.0). The cycling reaction was allowed to proceed for 30 minutes at room temperature, and the concentration of NAD was determined based on the rate of resorufin accumulation, measured as fluorescence at excitation at 544 nm and emission at 590 nm. Reduced NAD was similarly extracted from 50 mg of clamp frozen liver tissue in prechilled extraction buffer (25 mM NH 4 Ac, 25 mM NaOH, 50% [vol/vol] acetonitrile) bubbled with nitrogen gas. Alkaline lysates were mixed 1:1 (vol/vol) with ethanol extraction buffer (250 mM KOH, 50% [vol/vol] ethanol) and heated at 558C for 10 minutes. Lysate supernatants were diluted 1:50 in ice-cold 100 mM phosphate buffer, pH 8, for reduced NAD measurement by cycling assay.
HEPATIC TRIGLYCERIDE ASSAY
Snap-frozen liver tissue (25 mg) was extracted in cell lysis buffer (140 mM NaCl, 50 mM trishydroxymethylaminomethane, pH 7.4, 0.1% Triton-X) using a tissue lyzer. Samples were centrifuged for 15 minutes at 15,000 g, and triglycerides were assayed with the Triglyceride Assay Kit (Stanbio) using glycerol as a standard.
ATP DETERMINATION
ATP was measured in neutralized acid extracts of 50 mg of snap-frozen liver using an ATP determination kit (Life Technologies) according to the manufacturer's protocol.
GLUCOSE MEASUREMENT
Blood glucose values were measured from the tail vein using a OneTouch Ultra glucose analyzer after an overnight (16 hours) fast or under random fed conditions.
FREE FATTY ACID ASSAY
Plasma nonesterified fatty acid was measured using a free fatty acid (FFA) kit (Sigma-Aldrich; MAK044).
STATISTICS
All results are expressed as mean 6 standard error of the mean. Comparisons between two groups were analyzed using an unpaired two-tailed Student t test. Comparisons between three or more groups were analyzed using one-way analysis of variance in Prism 6 (GraphPad), followed by post hoc analysis with the Student t test. For correlation matrices, data were analyzed using Pearson correlation coefficients. Differences between means were defined as significant at P < 0.05. 
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Results
NR PROMOTES LIVER REGENERATION
To test whether NAD availability limits the rate of liver regeneration, we supplemented the drinking water of WT C57BL/6J mice with NR (3 mg/mL, 500 mg/kg) beginning 14 days prior to two-thirds PHx. While regenerating livers from control mice were pale with a characteristic mottled pattern at early time points after PHx, those from NR-treated mice were more uniformly colored (Fig. 1A, left) and displayed greatly enhanced hepatocyte proliferation, as assessed by incorporation of EdU into DNA (Fig. 1A,B) or Ki-67 immunostaining (Supporting Fig. S1 ). Consistently, expression of cyclin D1 and cyclin-dependent kinase 4 was increased in NR-treated mice at 24 hours post-PHx (Supporting Fig. S1B ). Increased hepatocyte replication was reflected by a significant improvement in liver mass at early time points and a trend toward increased mass even at 8 days, when regeneration is considered complete (14) (Fig. 1C) . Notably, we did not observe changes in the size of the liver in control mice given NR, and there was no difference in the weights of the resected lobes between the two groups (Supporting Fig. S1C ). In addition, while both groups of mice lost weight after surgery, body weight stabilized more quickly in the NR-treated mice than in controls (Supporting Fig. S1D ). As expected, NAD content was increased in the livers of NR-treated mice both prePHx (22%) and post-PHx (42%, at 48 hours) and remained significantly elevated through 192 hours (Fig. 1D) . In general, reduced NAD content moved in parallel with that of NAD, such that there was no major shift in redox potential (Supporting Fig. S1E) .
Analysis of hematoxylin and eosin-stained sections revealed a 48% increase in mitotic activity in the presence of NR (Fig. 1E) . Moreover, the fatty changes characteristic of early stages of liver regeneration, while readily apparent in controls, were reduced at 24 hours post-PHX in NR-treated mice and nearly absent by 48 hours. Hepatic steatosis was characterized by the presence of both microvesicular and macrovesicular lipid droplets (Fig. 1F, left) as well as accumulation of hepatic triglycerides (Fig. 1F, right) . Glycemia and circulating FFAs were similar between the two groups, although NR-treated mice had very slightly higher glucose levels pre-PHx and a slightly but significantly lower FFA level immediately following PHx (Supporting Fig. S1F) . Thus, NR treatment is sufficient to increase hepatic NAD content and significantly promotes liver regeneration while ameliorating fatty changes.
HEPATOCYTE-SPECIFIC Nampt OVEREXPRESSION RECAPITULATES THE EFFECTS OF SYSTEMIC NR ON LIVER REGENERATION
Because oral NR may have systemic effects that influence the rate of liver regeneration, we next wanted to test whether NAD synthesis specifically in hepatocytes is sufficient to recapitulate our observations. We employed a strain of mice that overexpress Nampt in a Cre-inducible manner (8) crossed to mice expressing Cre under the control of the albumin promoter ( Fig. 2A, left) . Nampt overexpression was not uniform (Fig. 2A, right) and was markedly more prominent near the periportal and central venous areas. By 48 hours following PHx, Namptoverexpressing livers appeared darker and more uniform in color (Fig. 2B, left) and, as was observed with NR treatment, had dramatically enhanced EdU incorporation (Fig.  2B, right) . These changes correlated with an increase in the size of regenerated livers (Fig. 2C, left) . Notably, hepatocyte-specific overexpression of Nampt did not affect body or liver weight prior to surgery (Fig. 1C and data not  shown) , although we noted a mild elevation of fasting glucose levels (Fig. 2C, right) . Liver NAD content was significantly elevated both pre-PHx and post-PHx (Fig. 2D) . Mitotic indices were increased, and accumulation of lipid droplets and triglyceride content were dramatically decreased (Fig. 2E,F) . Accordingly, liver-specific enhancement of NAD biosynthesis recapitulates the key effects of systemic NR treatment on liver regeneration.
ADULT-ONSET OVEREXPRESSION IS SUFFICIENT FOR THE BENEFICIAL EFFECTS OF Nampt
To exclude the possibility that improved regeneration in Nampt-overexpressing mice could be secondary to metabolic adaptations in early life, we performed a second set of experiments in which Cre was delivered by AAV in adult mice. Nampt-overexpressing mice from this experiment were compared to two distinct sets of littermate controls: those carrying the floxed allele and infected with AAV encoding GFP and WT mice infected with AAV-Cre. Mice that overexpressed Nampt in their livers only during adulthood (Fig. 3A) displayed mildly elevated fasting glucose (Fig. 3B) , darker color, increased mass, and enhanced hepatocellular proliferation (Fig. 3C,D) , similar to the results obtained in mice with lifelong overexpression. Whereas the previous groups of mice were sacrificed at 48 hours post-PHx to allow quantification of mitotic figures, the adult-onset group was sacrificed at 36 hours to capture the peak of DNA synthesis (Fig. 3D) . As in the previous experiments, Nampt overexpression attenuated acute hepatic steatosis and accumulation of hepatic triglycerides (Fig. 3E,F) .
HEPATOCYTE-SPECIFIC DELETION OF Nampt IMPAIRS LIVER REGENERATION AND IS COMPLETELY RESCUED BY NR
Nampt is secreted from adipose tissue and immune cells, and the extracellular form remains catalytically active. (9, 15, 16) Nampt secretion from primary hepatocytes has also been observed, (17) and therefore, it remains formally possible that overexpression of Nampt in hepatocytes from our transgenic mice leads to spillover into the circulation that could have NADdependent effects in other cell types. Moreover, extracellular Nampt has been proposed to have functions that are independent of its catalytic activity, (18) raising the possibility that NR and Nampt overexpression could work through independent pathways to influence liver regeneration. To address these points, we generated hepatocyte-specific Nampt-deficient mice by injecting AAV-Cre into adult animals bearing two floxed alleles for Nampt (Fig. 4A) . Littermates carrying the floxed allele that were infected with AAV-GFP served as controls. Five days after infection, half of the mice in each group were placed on drinking water containing NR and treated for an additional 2 weeks prior to PHx. Macroscopically, regenerated livers of N fl/flAAV-Cre mice were pale with petechial hemorrhage, which was prevented by NR treatment (Fig. 4B) . Liver regeneration during the first 48 hours after PHx was markedly compromised in Nampt knockout mice and restored by NR treatment (Fig. 4C) , which effectively increased NAD content in both genotypes (Fig. 4D) . Consistently, NR treatment largely restored mitotic index in Nampt knockout mice (Fig. 4E) , and again there was no change in the weight of the resected lobes, indicating that all livers were normal size prior to injury.
Histological examination revealed dramatic hepatic steatosis in N fl/flAAV-Cre mice, comprising both microvesicular and macrovesicular lipid droplets (Fig. 4F , left upper panels). In contrast, NR abolished hepatic lipid accumulation in regenerating WT livers and nearly normalized hepatic fatty changes in NAMPTdeficient regenerating livers (Fig. 4F, left lower panels) . Hepatic triglycerides were also reduced by 75% in N fl/flAAV-Gfp and 35% in N fl/flAAV-Cre mice with NR treatment (Fig. 4F, right) . Our results demonstrate that loss of endogenous Nampt expression in hepatocytes impairs liver regeneration and deteriorates lipid metabolism and that supplementation with an NAD precursor is sufficient to ameliorate these changes.
LIVER NAD CONTENT STRONGLY CORRELATES WITH ENERGY STATUS, TRIGLYCERIDE ACCUMULATION, AND HEPATOCYTE PROLIFERATION
To gain further insight into the relationships between NAD, lipid metabolism, and hepatocyte proliferation, we tested whether these correlations hold true at the level of individual animals. Hepatocyte proliferation displays a striking positive correlation with liver NAD content and an inverse correlation with hepatic triglycerides (Fig. 5A,B) . We speculated that this could reflect the need for optimal NAD levels to allow oxidation of lipids to provide energy for cell growth and division, either due to the direct requirement for NAD in the 3-hydroxyacyl-coenzyme A dehydrogenase-catalyzed step of fatty acid oxidation and the tricarboxylic acid cycle or due to its role as a cosubstrate for signaling enzymes such as sirtuins. ATP levels have been reported to drop rapidly (within 30 seconds) after PHx independently from energetic demand. (19) Consistent with the hypothesis that optimal NAD levels are required to facilitate the use of lipids as a fuel source, NR treatment greatly accelerated the recovery Hepatic NAD promotes fatty acid oxidation, thereby generating the ATP necessary for hepatocellular growth and regeneration. NAD is directly required in the 3-hydroxyacyl-coenzyme A dehydrogenase-catalyzed step of fatty acid oxidation as well as the tricarboxylic acid cycle but may also act indirectly through signaling enzymes such as Sirt1, which use NAD as a cosubstrate. NAD concentration can be modulated based on the expression of Nampt, which catalyzes the formation of nicotinamide mononucleotide from nicotinamide and phosphoribosylpyrophosphate. Alternatively, nicotinamide mononucleotide can be generated from NR by the action of NR kinase. Error bars represent standard error of the mean: *P < 0.05, **P < 0.01. Abbreviations: HADH, 3-hydroxyacyl-coenzyme A dehydrogenase; NAM, nicotinamide; NMN, nicotinamide mononucleotide; TCA, tricarboxylic acid cycle; TG, triglycerides.
of ATP concentration during regeneration (75% increase at 48 hours post-PHx; Fig. 5C ). Moreover, ATP content correlated positively with both NAD and hepatocyte proliferation (Fig. 5D,E) , suggesting that NR can alleviate the energetic stress imposed by ongoing regeneration in the liver.
NR ENHANCES EXPRESSION OF LIPOLYTIC GENES DURING REGENERATION
NR has been proposed to alleviate hepatic steatosis through induction of the mitochondrial unfolded protein response and subsequent induction of genes related to beta-oxidation and mitochondrial biogenesis as well as widespread suppression of genes related to lipogenesis. (20) In contrast, NR treatment does not induce the mitochondrial unfolded protein response or have a consistent effect on the expression of mitochondrial genes in the regenerating liver (Fig. 6A) . Instead, we observed selective induction of adipocyte triglyceride lipase (Atgl) and perilipin 2 and suppression of acetyl-coenzyme A carboxylase 2 (Acc2) in NR-treated regenerating livers (Fig. 6B) . Atgl catalyzes the first step in triglyceride breakdown, whereas perilipins coat lipid droplets and regulate fat mobilization. Acc2 is the primary enzyme responsible for producing malonyl-coenzyme A, which inhibits transport of fatty acids into the mitochondria. (21) Thus, the gene expression profile induced by NR in the regenerating liver is consistent with enhanced breakdown of neutral lipids and import of the resulting fatty acids to mitochondria. Interestingly, hepatocytespecific overexpression of Nampt was also sufficient to induce Atgl and perilipin 2 expression, suggesting that this is a tissue autonomous effect (Supporting Fig. S2 ).
Discussion
We have shown for the first time that a supplemental NAD precursor can improve the outcome in an experimental model of liver injury. Consistently, recovery from PHx is also influenced by the expression level of Nampt in hepatocytes, and poor regeneration in mice lacking Nampt is completely rescued by NR.
Previous studies have attributed the lower NAD concentration in regenerating livers to competition for common metabolic precursors and cofactors that are also required for synthesis of nucleic acids. (4) (5) (6) 22, 23) NR is taken up by cells and phosphorylated to nicotinamide mononucleotide, thereby sparing one molecule of phosphoribosylpyrophosphate (with a net gain of one highenergy phosphate bond from ATP) compared to conventional synthesis from nicotinamide. Genetically altering Nampt expression, however, does not introduce new metabolic precursors and yet is able to replicate the effect of NR. This suggests two possible explanations. (1) The expansion or contraction of the hepatocyte NAD pool prior to injury might be sufficient to confer the corresponding increase or decrease in regenerative capacity. This seems plausible given that the transient loss of NAD during regeneration occurs prior to the first cell division, and thus, a modest increase in preformed NAD might insulate a hepatocyte from this effect. (2) The natural course of regeneration from severe injuries might be inappropriately skewed toward nucleic acid synthesis at the expense of NAD, such that tipping the balance back toward NAD has a favorable effect overall. In support of the latter hypothesis, it was recently shown that supplemental nicotinamide is protective against acetaminophen-induced liver toxicity, even when administered after the injury. (24) In this vein, it may also be interesting to examine the activity of nicotinamide Nmethyl transferase, which can limit the production of NAD by competing for nicotinamide. (25) Given that NAD is required for ATP synthesis and ATP is required to make NAD, the potential for an intractable energetic crisis can be envisioned if NAD levels are allowed to dip too low. Indeed, this appears to be the major mechanism of action for cancer drugs that target Nampt activity. (26) Transient hepatic steatosis is a characteristic feature of liver regeneration. (27) (28) (29) In other experimental settings, Nampt has been suggested to confer resistance to hepatic steatosis through NAD synthesis, (30) and it was recently shown that NR supplementation confers protection against steatosis in mice fed a high-fat/highsucrose diet. (20, 31) These findings are in good agreement with our observation that steatosis is almost completely absent at 48 hours after PHx in mice given NR or overexpressing Nampt in hepatocytes. However, it will be important to determine whether these observations reflect a common underlying mechanism. Much of the triglyceride accumulation following PHx likely results from increased esterification of FFAs, (32) which are released by adipose tissue in response to a fall in insulin. Thus, a molecule that preserves glucose (and, consequently, insulin) levels might decrease fat accumulation in the liver by preventing FFA release from adipose tissue. Our data suggest that this mechanism plays only a minor role in the prevention of steatosis by NR as circulating glucose and FFA levels are similar through most of the experiment (Supporting Fig. S1F ). Moreover, some steatosis was visible in NR-treated mice at 24 hours post-PHx, supporting the possibility that lipids accumulate normally during regeneration in the presence of enhanced NAD synthesis but are cleared more quickly. This would be consistent with a model where lipids are processed by the regenerating liver in an NAD-sensitive manner to provide a source of energy while sparing glucose for output into the bloodstream or use as a metabolic precursor. In the absence of sufficient NAD concentration, lipid oxidation and consequently ATP levels would fall, halting cell proliferation.
While increasing NAD availability might improve regeneration solely through its role as a cofactor for enzymes directly involved in ATP production and/or by sparing precursors for nucleic acid synthesis, NAD could also act through its role as a cosubstrate for signaling enzymes, including the sirtuins. Importantly, steady-state measurements of NAD do not necessarily reflect changes in flux through such enzymes as decreased synthesis of NAD cannot be distinguished from increased use. However, Nampt is known to influence the deacetylase activity of the sirtuin 1 (Sirt1), (16, 33, 34) and the ability of NR to ameliorate steatosis in the context of a high-fat diet requires the induction of a Sirt1-dependent transcriptional program to support b-oxidation. (20) While we detected only a limited overlap with this transcriptional program, our profiling revealed the induction of Atgl and perilipin 2 and suppression of Acc2 in NR-treated regenerating livers, all of which catalyze key steps in the breakdown of triglycerides and mitochondrial import of the liberated fatty acids. Whole-body disruption of perilipin 2 has been shown to reduce hepatic lipid accumulation and weight gain in mice fed a high-fat diet, (35, 36) which is contrary to our observation that increased expression correlates with decreased triglyceride content in regenerating livers. However, perilipin 2 can have complex and context-dependent effects on hepatic lipid metabolism, (37, 38) and the effects of constitutive deletion may be at least partially related to reduced food intake and increased energy expenditure, rather than to primary effects on hepatic lipid storage. (39) Indeed, it has recently been shown that perilipin 2 plays an unexpected positive role in adipocyte lipolysis (40, 41) and promotes lipid oxidation through chaperone-mediated autophagy in mouse hepatocytes. (42) It will be intriguing to test whether the induction that we observe in regenerating hepatocytes has similar consequences. Overall, our data support a model where steatosis is counteracted by increased lipolysis and fatty acid use when NAD levels are maintained.
Recent studies have suggested roles for Sirt1 in hepatic lipid metabolism (43) and liver regeneration. (44, 45) Jin et al. showed that old mice with impaired liver regeneration express low hepatic Sirt1 and that ectopically expressing Sirt1 restores hepatocyte proliferation in response to PHx in old mice, whereas knockdown of Sirt1 impairs regeneration in young mice. (45) In contrast, Garcia-Rodriguez et al. showed that young mice overexpressing Sirt1 have increased mortality following PHx due to defects in bile acid regulation. (44) Tao et al. showed that Nampt expression reduces hepatocyte triglyceride levels in uninjured livers and that the effect is correlated with increased Sirt1 activity as well as phenocopied by overexpressing Sirt1. (30) Accordingly, the reduction in steatosis that we observe with enhanced NAD regeneration may reflect a Sirt1-dependent effect on lipid metabolism. In addition, resveratrol, a small polyphenol that activates Sirt1, has been shown to improve hepatocyte survival in injury models but also to slow replication. (46) Thus, it remains unclear whether Sirt1 activation per se could account for the beneficial effects of enhanced NAD synthesis on liver regeneration, and it will be intriguing to test the requirement for Sirt1 using knockout models.
Overall, we present the first evidence that NAD metabolism can be modulated to promote recovery from liver injury. As our findings suggest that NAD precursors may be therapeutic in a variety of settings requiring liver regeneration, further investigation into downstream mechanisms and optimal delivery strategies is warranted.
